AndreasenAH, BrøsenK, DamkierP: A comparative pharmacokinetic study in healthy volunteers of the effect of carbamazepine and oxcarbazepine on cyp3a4. Epilepsia, 48:490–496, 2007.
2.
de LeonJ: False-negative studies may systematically contaminate the literature on the effects of inducers in neuropsychopharmacology. Part II: Focus on bipolar disorder. J Clin Psychopharmacol, 34:291–296, 2014.
3.
DouglasJ, SandersK, BenneyworthM, SmithJ, DeJeanV, McGrewSG, Veenstra-VanderweeleJ: Brief report: Retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism spectrum disorder. J Autism Dev Disord, 43:1243–1247, 2013.
4.
GrimmSW, RichtandNM, WinterHR, StamsKR, ReeleSB: Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics. Br J Clin Pharmacol, 61:58–69, 2005.
